| 2019-11 |
Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric Cancer |
ONCOLOGIST
|
| 2019-11 |
A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer. |
GASTRIC CANCER
|
| 2019-11 |
Inhibiting casein kinase 2 overcomes paclitaxel resistance in gastric cancer |
GASTRIC CANCER
|
| 2019-10 |
Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer |
Journal for ImmunoTherapy of Cancer
|
| 2019-10 |
Characteristics and Treatment Patterns of Patients with Advanced Soft Tissue Sarcoma in Korea |
CANCER RESEARCH AND TREATMENT
|
| 2019-10 |
Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma. |
CANCER RESEARCH AND TREATMENT
|
| 2019-07 |
Significance of Metabolic Tumor Volume and Total Lesion Glycolysis Measured Using ¹⁸F-FDG PET/CT in Locally Advanced and Metastatic Gallbladder Carcinoma. |
YONSEI MEDICAL JOURNAL
|
| 2019-07 |
Behaviors and Attitudes toward the Use of Complementary and Alternative Medicine among Korean Cancer Patients |
CANCER RESEARCH AND TREATMENT
|
| 2019-07 |
Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancer |
RADIOTHERAPY AND ONCOLOGY
|
| 2019-05 |
Stability of symptom clusters and sentinel symptoms during the first two cycles of adjuvant chemotherapy |
SUPPORTIVE CARE IN CANCER
|
| 2019-05 |
Lenvatinib plus everolimus or pembrolizumab versus sunitinib in advanced renal cell carcinoma: study design and rationale |
FUTURE ONCOLOGY
|
| 2019-05 |
EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group |
BMC CANCER
|
| 2019-05 |
Randomised phase II trial comparing four front-line doublets in Asian patients with metastatic gastric cancer. |
EUROPEAN JOURNAL OF CANCER
|
| 2019-04 |
Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial |
CANCER RESEARCH AND TREATMENT
|
| 2019-02 |
Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma. |
ONCOLOGY
|
| 2019-02 |
Avelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: Phase 1b results from the JAVELIN Solid Tumor trial |
Journal for ImmunoTherapy of Cancer
|
| 2019-01 |
Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients |
CANCER RESEARCH AND TREATMENT
|
| 2019-01 |
S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial |
CANCER RESEARCH AND TREATMENT
|
| 2019-01 |
The clinical implications of FDG-PET/CT differ according to histology in advanced gastric cancer. |
GASTRIC CANCER
|
| 2018-12 |
Regulation of proliferation and invasion by the IGF signalling pathway in Epstein-Barr virus-positive gastric cancer. |
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
|
| 2018-11 |
Renal Cell Carcinoma Is Abrogated by p53 Stabilization through Transglutaminase 2 Inhibition |
Cancers
|
| 2018-11 |
Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy |
BMC CANCER
|
| 2018-11 |
Casein Kinase 2 Inhibitor, CX-4945, as a Potential Targeted Anticancer Agent in Gastric Cancer. |
ANTICANCER RESEARCH
|
| 2018-11 |
Real-Time Tumor Gene Expression Profiling to Direct Gastric Cancer Chemotherapy: Proof-of-Concept "3G" Trial. |
CLINICAL CANCER RESEARCH
|
| 2018-10 |
BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
|
| 2018-10 |
Genetic Alterations among Korean Melanoma Patients Showing Tumor Heterogeneity: A Comparison between Primary Tumors and Corresponding Metastatic Lesions. |
CANCER RESEARCH AND TREATMENT
|
| 2018-10 |
Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial. |
ANNALS OF SURGICAL ONCOLOGY
|
| 2018-09 |
Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma. |
BRITISH JOURNAL OF CANCER
|
| 2018-09 |
Reconsideration of sample size and power calculation for overall survival in cancer clinical trials |
Contemporary clinical trials communications
|
| 2018-09 |
Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG). |
GASTRIC CANCER
|
| 2018-07 |
CpG Island Methylator Phenotype and Methylation of Wnt Pathway Genes Together Predict Survival in Patients with Colorectal Cancer |
YONSEI MEDICAL JOURNAL
|
| 2018-07 |
Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitor |
INTERNATIONAL JOURNAL OF CANCER
|
| 2018-06 |
MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis |
JOURNAL OF SURGICAL ONCOLOGY
|
| 2018-05 |
A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and Chemotherapy |
AAPS JOURNAL
|
| 2018-03 |
The prognostic value of volume-based parameters using 18F-FDG PET/CT in gastric cancer according to HER2 status |
GASTRIC CANCER
|
| 2018-03 |
The Benefit of Pro Re Nata Antiemetics Provided With Guideline-Consistent Antiemetics in Delayed Nausea Control. |
CANCER NURSING
|
| 2018-03 |
Retrospective analysis of palliative chemotherapy for the patients with bladder adenocarcinoma: Korean Cancer Study Group Genitourinary and Gynecology Cancer Committee. |
KOREAN JOURNAL OF INTERNAL MEDICINE
|
| 2018-02 |
Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcoma. |
BMC CANCER
|
| 2018-01 |
Rab25 augments cancer cell invasiveness through a β1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin |
EXPERIMENTAL AND MOLECULAR MEDICINE
|
| 2017-12 |
PTEN loss and level of HER2 amplification is associated with trastuzumab resistance and prognosis in HER2-positive gastric cancer |
ONCOTARGET
|
| 2017-12 |
A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors |
INVESTIGATIONAL NEW DRUGS
|
| 2017-10 |
A first-time-in-human study of GSK2636771, a phosphoinositide 3 kinase beta-selective inhibitor, in patients with advanced solid tumors |
CLINICAL CANCER RESEARCH
|
| 2017-10 |
Integration of radiotherapy and chemotherapy for abdominal lymph node recurrence in gastric cancer |
CLINICAL & TRANSLATIONAL ONCOLOGY
|
| 2017-09 |
Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer |
ONCOTARGET
|
| 2017-08 |
Modulation of HAT activity by the BRCA2 N372H variation is a novel mechanism of paclitaxel resistance in breast cancer cell lines |
BIOCHEMICAL PHARMACOLOGY
|
| 2017-08 |
Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer |
ONCOLOGY LETTERS
|
| 2017-06 |
Epigenomic Promoter Alterations Amplify Gene Isoform and Immunogenic Diversity in Gastric Adenocarcinoma |
CANCER DISCOVERY
|
| 2017-06 |
Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC |
ANNALS OF ONCOLOGY
|
| 2017-06 |
Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma |
CLINICAL GENITOURINARY CANCER
|
| 2017-06 |
Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancer |
BRITISH JOURNAL OF SURGERY
|
| 2017-06 |
Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer |
ONCOTARGET
|
| 2017-05 |
Symptom clusters during palliative chemotherapy and their influence on functioning and quality of life |
SUPPORTIVE CARE IN CANCER
|
| 2017-05 |
Characterizing the outcomes of metastatic papillary renal cell carcinoma |
CANCER MEDICINE
|
| 2017-05 |
Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab. |
ONCOTARGET
|
| 2017-05 |
Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents. |
CLINICAL NUCLEAR MEDICINE
|
| 2017-05 |
Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia |
ANNALS OF SURGERY
|
| 2017-04 |
Prevalence and prognostic implications of psychological distress in patients with gastric cancer |
BMC CANCER
|
| 2017-03 |
Different subtypes of epithelioid sarcoma and their clinical implication: long-term multi-institutional experience with a rare sarcoma |
APMIS
|
| 2017-01 |
Telomerase reverse transcriptase (TERT) promoter mutations in Korean melanoma patients |
AMERICAN JOURNAL OF CANCER RESEARCH
|
| 2017-01 |
ABCB1 2677G>T/A variant enhances chemosensitivity to anti-cancer agents acting on microtubule dynamics through LAMP1 inhibition |
BIOCHEMICAL PHARMACOLOGY
|
| 2016-12 |
Epstein-Barr virus BARF1-induced NFκB/miR-146a/SMAD4 alterations in stomach cancer cells |
ONCOTARGET
|
| 2016-12 |
Recursive Partition Analysis of Peritoneal and Systemic Recurrence in Patients With Gastric Cancer Who Underwent D2 Gastrectomy: Implications for Neoadjuvant Therapy Consideration |
JOURNAL OF SURGICAL ONCOLOGY
|
| 2016-11 |
Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithm |
ONCOTARGET
|
| 2016-11 |
Gaps exist between patients' experience and clinicians' awareness of symptoms after chemotherapy: CINV and accompanying symptoms |
SUPPORTIVE CARE IN CANCER
|
| 2016-10 |
ADAR-mediated RNA editing predicts progression and prognosis of Gastric Cancer. |
GASTROENTEROLOGY
|
| 2016-10 |
Efficacy and Toxicity of Mammalian Target Rapamycin Inhibitors in Patients with Metastatic Renal Cell Carcinoma with Renal Insufficiency: The Korean Cancer Study Group GU 14-08. |
CANCER RESEARCH AND TREATMENT
|
| 2016-09 |
Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity. |
NATURE COMMUNICATIONS
|
| 2016-09 |
A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma |
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE
|
| 2016-09 |
A Phase II Biomarker-Embedded Study of Lapatinib plus Capecitabine as First-line Therapy in Patients with Advanced or Metastatic Gastric Cancer. |
MOLECULAR CANCER THERAPEUTICS
|
| 2016-09 |
High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer |
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
|
| 2016-08 |
Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial |
JOURNAL OF CLINICAL ONCOLOGY
|
| 2016-08 |
Controlling chemotherapy-induced nausea requires further improvement: symptom experience and risk factors among Korean patients |
SUPPORTIVE CARE IN CANCER
|
| 2016-07 |
Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma. |
BMC CANCER
|
| 2016-07 |
Rho GTPase RhoJ is Associated with Gastric Cancer Progression and Metastasis |
JOURNAL OF CANCER
|
| 2016-07 |
Bone alkaline phosphatase as a surrogate marker of bone metastasis in gastric cancer patients |
BMC CANCER
|
| 2016-07 |
Fibroblast Growth Factor Receptor 1 Overexpression Is Associated with Poor Survival in Patients with Resected Muscle Invasive Urothelial Carcinoma |
YONSEI MEDICAL JOURNAL
|
| 2016-06 |
Prognostic significance and frequency of EGFR expression and amplification in surgically resected advanced gastric cancer |
JAPANESE JOURNAL OF CLINICAL ONCOLOGY
|
| 2016-06 |
Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: Implications for individualized therapy |
ONCOTARGET
|
| 2016-06 |
Prognostic Model to Predict Survival Outcome for Curatively Resected Liposarcoma: A Multi-Institutional Experience. |
JOURNAL OF CANCER
|
| 2016-05 |
Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma |
ANNALS OF NUCLEAR MEDICINE
|
| 2016-05 |
Promoter Methylation of PTEN Is a Significant Prognostic Factor in Melanoma Survival |
JOURNAL OF INVESTIGATIVE DERMATOLOGY
|
| 2016-04 |
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial |
LANCET
|
| 2016-04 |
A Retrospective Analysis for Patients with HER2-Positive Gastric Cancer Who Were Treated with Trastuzumab-Based Chemotherapy: In the Perspectives of Ethnicity and Histology |
CANCER RESEARCH AND TREATMENT
|
| 2016-04 |
Prognostic implications of PIK3CA amplification in curatively resected liposarcoma |
ONCOTARGET
|
| 2016-04 |
Assessment of Adrenal Function and Health-Related Quality of Life in Advanced Gastric Cancer Patients Who Received First-Line Chemotherapy |
ONCOLOGY
|
| 2016-04 |
PTEN Methylation Dependent Sinonasal Mucosal Melanoma |
CANCER RESEARCH AND TREATMENT
|
| 2016-03 |
Cranofacial osteosarcoma: Single institutional experience in Korea |
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
|
| 2016-02 |
Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites |
ONCOTARGET
|
| 2016-02 |
Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. |
CANCER
|
| 2016-01 |
Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity |
ONCOTARGET
|
| 2016-01 |
Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy |
ANNALS OF SURGERY
|
| 2016-01 |
p16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic Colorectal Cancer |
CANCER RESEARCH AND TREATMENT
|